# Human Longevity and Performance Impact Venture Fund

> Human Longevity and Performance Impact Venture Fund is a VC fund backing Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 2
- Last investment: Feb 2022
- Lead investor: 50%
- Last updated: Aug 2026

Human Longevity and Performance Impact Venture Fund is a longevity focused early-stage venture capital fund dedicated to providing resources, insight, and leadership to companies whose mission is to improve human health and drive longevity through technology, predictive analytics, research, and patient care. HLPIVF is establishing a synergisticecosystem of longevity and performance-focused companies to dramatically increase the volume and effectiveness of life-affirming diagnostics and therapeutics.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 100% |
| Biotechnology | 1 | 50% |
| Artificial Intelligence | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Hong Kong | 1 | 50% |
| United States | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Huma.AI | Healthcare is extremely inefficient due to complex and disparate systems that don’t talk to each other. The explosion of data further compounds the problem. Huma.AI improves (if not solves) this inefficiency by serving as the connective tissue between system silos allowing “mere mortals” to automatically access data, gain insights and take actionusing everyday language. | $9.5M | Series A | Feb 03, 2022 | http://www.huma.ai |
| Deep Longevity | Deep Longevity is a biotechnology company transforming longevity R&D through AI-discovered biomarkers of aging using clinical blood tests, transcriptomic, proteomic, epigenetic, microbiome, behavioral, wearable, imaging, and multiple other data types. |  | Series A | Jul 14, 2020 | https://deeplongevity.com/ |

2 of 2 investments shown.

## Co-investors
- [Bold Capital Partners](https://shizune.co/investors/profile/bold-capital) — VC Fund, 1 deal together
- [Boston Millennia Partners](https://shizune.co/investors/profile/boston-millennia-partners) — VC Fund, 1 deal together
- [Emerging Technology Partners](https://shizune.co/investors/profile/emerging-technology-partners) — VC Fund, 1 deal together
- [ETP Ventures](https://shizune.co/investors/profile/etp-ventures) — VC Fund, 1 deal together
- [Excelerate Health Ventures](https://shizune.co/investors/profile/excelerate-health-ventures) — VC Fund, 1 deal together
- [Formic Ventures](https://shizune.co/investors/profile/formic-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Alibaba Entrepreneurs Fund](https://shizune.co/investors/profile/alibaba-entrepreneurs-fund) — VC Fund
- [Animoca Brands](https://shizune.co/investors/profile/animoca-brands-corporation) — VC Fund
- [Gobi Partners](https://shizune.co/investors/profile/gobi-partners) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Hong Kong](https://shizune.co/investors/biotechnology-investors-hong-kong)
- [Biotechnology VC Funds in Hong Kong](https://shizune.co/investors/biotechnology-vc-funds-hong-kong)
- [Biotech VC Funds in Hong Kong](https://shizune.co/investors/biotech-vc-funds-hong-kong)
- [Health Care VC Funds in Hong Kong](https://shizune.co/investors/health-care-vc-funds-hong-kong)

## FAQ

### What does Human Longevity and Performance Impact Venture Fund invest in?

Human Longevity and Performance Impact Venture Fund invests primarily in Health Care, Biotechnology and Artificial Intelligence startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in Hong Kong. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Human Longevity and Performance Impact Venture Fund last invest?

The most recent investment recorded for Human Longevity and Performance Impact Venture Fund closed in Feb 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co